Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.18 - $0.86 $41,478 - $198,174
230,436 Added 248.19%
323,282 $84,000
Q1 2022

May 17, 2022

BUY
$0.6 - $1.06 $35,059 - $61,937
58,432 Added 169.79%
92,846 $56,000
Q4 2021

Feb 17, 2022

BUY
$0.85 - $1.4 $18,258 - $30,073
21,481 Added 166.09%
34,414 $31,000
Q3 2021

Nov 12, 2021

SELL
$1.33 - $1.77 $28,850 - $38,394
-21,692 Reduced 62.65%
12,933 $17,000
Q2 2021

Sep 17, 2021

BUY
$1.41 - $1.94 $48,821 - $67,172
34,625 New
34,625 $50,000
Q1 2021

May 19, 2021

SELL
$1.61 - $2.77 $224,002 - $385,395
-139,132 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$1.55 - $2.24 $189,044 - $273,199
121,964 Added 710.41%
139,132 $243,000
Q3 2020

Dec 11, 2020

BUY
$1.91 - $3.08 $32,790 - $52,877
17,168 New
17,168 $33,000
Q2 2020

Aug 07, 2020

SELL
$1.97 - $3.98 $244,252 - $493,464
-123,986 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$1.16 - $1.42 $76,848 - $94,073
66,249 Added 114.74%
123,986 $153,000
Q3 2019

Nov 20, 2019

SELL
$1.21 - $1.65 $50,945 - $69,471
-42,104 Reduced 42.17%
57,737 $77,000
Q2 2019

Aug 13, 2019

BUY
$1.39 - $2.03 $138,778 - $202,677
99,841 New
99,841 $168,000
Q1 2019

Apr 12, 2019

SELL
$1.39 - $1.71 $127,678 - $157,072
-91,855 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$1.41 - $2.16 $2,628 - $4,026
-1,864 Reduced 1.99%
91,855 $132,000
Q3 2018

Nov 13, 2018

BUY
$1.86 - $2.18 $174,317 - $204,307
93,719 New
93,719 $197,000
Q2 2018

Jul 30, 2018

SELL
$1.76 - $2.79 $204,292 - $323,849
-116,075 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$1.76 - $2.79 $204,292 - $323,849
116,075 New
116,075 $229,000
Q1 2018

May 14, 2018

SELL
$1.34 - $2.03 $15,188 - $23,010
-11,335 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$1.65 - $2.45 $127,325 - $189,059
-77,167 Reduced 87.19%
11,335 $21,000
Q3 2017

Nov 15, 2017

BUY
$1.5 - $2.55 $132,753 - $225,680
88,502
88,502 $0

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.